Liphorus Pharmaceuticals Inc.

Pioneering compounds to combat hypercholesterolemia through innovative PCSK9 targeting.

General Information
Company Name
Liphorus Pharmaceuticals Inc.
Founded Year
2014
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
1
Industries
Pharmaceutical
Funding Stage
Series A
Social Media

Liphorus Pharmaceuticals Inc. - Company Profile

Liphorus Pharmaceuticals Inc. is a pharmaceutical startup founded in 2014 with a mission to combat hypercholesterolemia through innovative PCSK9 targeting. The company has garnered attention with their pioneering compounds and has recently received a $6.40M Series A investment on 06 November 2014 from Sanderling Ventures and Univalor. Liphorus Pharmaceuticals is focused on developing small molecules that inhibit PCSK9, and has successfully secured a research collaboration with the IRCM to create and validate these PCSK9-targeting compounds. With such strong financial support and strategic partnerships, the company shows promise in revolutionizing the treatment of hypercholesterolemia within the pharmaceutical industry.

Taxonomy: Pharmaceuticals, PCSK9 Inhibition, Hypercholesterolemia, Research Collaboration, Compound Development, Small Molecules, Medical Innovation, Investment Potential

Funding Rounds & Investors of Liphorus Pharmaceuticals Inc. (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A $6.40M 2 Univalor 06 Nov 2014

Latest News of Liphorus Pharmaceuticals Inc.

View All

No recent news or press coverage available for Liphorus Pharmaceuticals Inc..

Similar Companies to Liphorus Pharmaceuticals Inc.

View All
LIB Therapeutics - Similar company to Liphorus Pharmaceuticals Inc.
LIB Therapeutics Where lower is better!
Dicerna Pharmaceuticals - Similar company to Liphorus Pharmaceuticals Inc.
Dicerna Pharmaceuticals Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference technology.
Corvidane - Similar company to Liphorus Pharmaceuticals Inc.
Corvidane A novel approach to treating cardiovascular and liver diseases